Sprache auswählen

logo
Informationen
The Berlin Epidemiological Methods Colloquium (BEMC) invites all interested participants to its next session on Wednesda...

The Berlin Epidemiological Methods Colloquium (BEMC) invites all interested participants to its next session on Wednesday, May 7, 2025 at 4:00 PM CEST.


📣 Guest Speaker:
Martin Lajous (National Institute of Public Health, Mexico & Maria Sklodowska-Curie National Research Institute of Oncology, Poland)
🗣️ Talk Title: "Estimating effects on all-cause mortality in the presence of COVID-19 deaths"


In this presentation, Lajous will explore how the COVID-19 pandemic has introduced new challenges for epidemiologic cohorts evaluating the impact of risk factors on non-communicable disease mortality. Using data from the Mexican Teachers’ Cohort and the Polish-Norwegian Study, he will discuss patterns of mortality during and after the pandemic, and outline various causal inference methods for dealing with competing risks like COVID-19 deaths. The talk will also delve into advanced analytic strategies such as g-formula, IPTW, and separable treatment effects, including their application in real-world studies on colon and prostate cancer.


📍 Location (in-person): Lecture Hall 21 (former Paul-Ehrlich-Hörsaal), Virchowweg 4, CCM
📝 Register for in-person attendance
💻 Register for remote attendance via Zoom
📺 Not in Berlin? Join via livestream!


This is a great opportunity to engage with advanced epidemiological methods and gain insights into current debates in population health research.

Mehr
Neueste Fotos
Videos
Noch keine Videos hochgeladen
Link in Ihre Zwischenablage kopiert
Filter Timeline:
Gepinnte Beiträge
Neueste Aktivitäten
  • Hub Management Team hat eine neue Veranstaltung erstellt.

    BEMC Talk | Berlin Epidemiological Methods Colloquium (BEMC)

    The Berlin Epidemiological Methods Colloquium (BEMC) invites all interested participants to its next session on Wednesday, May 7, 2025 at 4:00 PM CEST.


    📣 Guest Speaker:
    Martin Lajous (National Institute of Public Health, Mexico & Maria Sklodowska-Curie National Research Institute of Oncology, Pol...

    The Berlin Epidemiological Methods Colloquium (BEMC) invites all interested participants to its next session on Wednesday, May 7, 2025 at 4:00 PM CEST.


    📣 Guest Speaker:
    Martin Lajous (National Institute of Public Health, Mexico & Maria Sklodowska-Curie National Research Institute of Oncology, Poland)
    🗣️ Talk Title: "Estimating effects on all-cause mortality in the presence of COVID-19 deaths"


    In this presentation, Lajous will explore how the COVID-19 pandemic has introduced new challenges for epidemiologic cohorts evaluating the impact of risk factors on non-communicable disease mortality. Using data from the Mexican Teachers’ Cohort and the Polish-Norwegian Study, he will discuss patterns of mortality during and after the pandemic, and outline various causal inference methods for dealing with competing risks like COVID-19 deaths. The talk will also delve into advanced analytic strategies such as g-formula, IPTW, and separable treatment effects, including their application in real-world studies on colon and prostate cancer.


    📍 Location (in-person): Lecture Hall 21 (former Paul-Ehrlich-Hörsaal), Virchowweg 4, CCM
    📝 Register for in-person attendance
    💻 Register for remote attendance via Zoom
    📺 Not in Berlin? Join via livestream!


    This is a great opportunity to engage with advanced epidemiological methods and gain insights into current debates in population health research.

    Mehr
    7th Mai, 2025
    0
    0
    0
    0
    0
    0
    Beitrag wartet auf Freischaltung
    Beitrag wurde veröffentlicht, er ist jetzt im Stream sichtbar.
Noch keine Aktivität vorhanden.
Fehler beim Laden das Tooltip
Wir benutzen Cookies

Wir nutzen Cookies auf unserer Website. Einige von ihnen sind essenziell für den Betrieb der Seite, während andere uns helfen, diese Website und die Nutzererfahrung zu verbessern (Tracking Cookies). Sie können selbst entscheiden, ob Sie die Cookies zulassen möchten. Bitte beachten Sie, dass bei einer Ablehnung womöglich nicht mehr alle Funktionalitäten der Seite zur Verfügung stehen.